T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECD
1651
DELISTED
Tech Data Corp
TECD
| $1.3M | ﹤0.01% |
20,580
+1,600
| +8% | +$95.9K |
|
1652
Omega Healthcare
OHI
$13.9B
| $1.29M | ﹤0.01% |
33,150
| – | – |
|
|
DHC
1653
Diversified Healthcare Trust
DHC
$2.02B
| $1.29M | ﹤0.01% |
58,738
| – | – |
|
|
IMI
1654
DELISTED
Intermolecular, Inc.
IMI
| $1.28M | ﹤0.01% |
663,000
| – | – |
|
1655
Zebra Technologies
ZBRA
$17.9B
| $1.27M | ﹤0.01% |
16,386
-171,443
| -91% | -$12.3M |
|
|
HNT
1656
DELISTED
HEALTH NET INC
HNT
| $1.26M | ﹤0.01% |
23,630
-2,700
| -10% | -$133K |
|
1657
iShares MSCI Japan ETF
EWJ
$23.2B
| $1.26M | ﹤0.01% |
28,025
+9,450
| +51% | +$434K |
|
1658
Enbridge
ENB
$112B
| $1.26M | ﹤0.01% |
24,400
+2,500
| +11% | +$118K |
|
1659
New Jersey Resources
NJR
$5.62B
| $1.25M | ﹤0.01% |
40,750
+6,400
| +19% | +$182K |
|
1660
DigitalBridge
DBRG
$2.95B
| $1.24M | ﹤0.01% |
13,709
+45
| +0.3% | +$3.56K |
|
1661
Groupon
GRPN
$901M
| $1.23M | ﹤0.01% |
7,441
-1,080
| -13% | -$153K |
|
1662
Spire
SR
$4.89B
| $1.22M | ﹤0.01% |
22,910
+2,600
| +13% | +$131K |
|
|
PNY
1663
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| $1.19M | ﹤0.01% |
30,300
| – | – |
|
1664
Owens Corning
OC
$12.3B
| $1.19M | ﹤0.01% |
33,200
-2,000
| -6% | -$66.5K |
|
1665
Lamar Advertising Co
LAMR
$15.6B
| $1.18M | ﹤0.01% |
21,992
+1,900
| +9% | +$98.1K |
|
|
DFRG
1666
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $1.18M | ﹤0.01% |
49,700
+2,500
| +5% | +$55.6K |
|
|
XLS
1667
DELISTED
EXELIS INC COM STK
XLS
| $1.18M | ﹤0.01% |
67,200
-14,300
| -18% | -$247K |
|
1668
The GEO Group
GEO
$4.14B
| $1.18M | ﹤0.01% |
43,700
+2,124
| +5% | +$55.4K |
|
1669
SITE Centers
SITC
$156M
| $1.17M | ﹤0.01% |
49,360
-13,504
| -21% | -$312K |
|
1670
Curtiss-Wright
CW
$26.7B
| $1.17M | ﹤0.01% |
16,500
| – | – |
|
1671
RenaissanceRe
RNR
$13.2B
| $1.16M | ﹤0.01% |
11,972
-828
| -6% | -$82.3K |
|
|
TUP
1672
DELISTED
Tupperware Brands Corporation
TUP
| $1.14M | ﹤0.01% |
18,120
-1,700
| -9% | -$111K |
|
|
WGL
1673
DELISTED
Wgl Holdings
WGL
| $1.14M | ﹤0.01% |
20,861
+121
| +0.6% | +$5.87K |
|
1674
MacroGenics
MGNX
$256M
| $1.14M | ﹤0.01% |
+32,426
| New | +$808K |
|
|
VVC
1675
DELISTED
Vectren Corporation
VVC
| $1.12M | ﹤0.01% |
24,249
+800
| +3% | +$35.1K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.